News

Opinion
Zacks Investment Research on MSN4hOpinion
Early Q2 Results Indicate an Improving Earnings Outlook
We get into the heart of the Q2 earnings season this week, with more than 400 companies on deck to report results, including 109 S&P 500 members. The reporting docket expands beyond the Finance core, ...
Pfizer Inc. (NYSE:PFE) Q2 2024 Earnings Conference Call July 30, 2024 10:30 AM ETCompany ParticipantsFrancesca DeMartino – Chief Investor Relations Officer ...
Pfizer (PFE) will report its second-quarter 2024 earnings on Jul 30, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $13.22 billion and 45 cents per share ...
Pfizer Q2 2022 Earnings Report Recap. ... PFE Outlook and Stock Performance . Pfizer affirmed its FY 2022 guidance for Comirnaty and Paxlovid revenue of roughly $32 billion and $22 billion, ...
Pfizer turned in a better-than-expected fourth quarter, boosted by products outside the drugmaker’s slumping COVID-19 vaccine and treatment.
Pfizer missed first quarter earnings Thursday amid a volatile macro environment. ... Pfizer reaffirmed its 2025 outlook of $61 to $64 billion in revenue and adjusted earnings per share of $2.80 to $3.
Pfizer (PFE) came out with quarterly earnings of $0.67 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $2.04 per share a year ago.
Pfizer (PFE) reported Q2 results that exceeded estimates. The pharmaceutical and biotech major reported adjusted diluted earnings of $0.60 per share in the second quarter, a decline of 11% year ...
Pfizer Inc. (NYSE:PFE) Q2 2023 Results Conference Call August 1, 2023 10:00 AM ETCompany ParticipantsChris Stevo - SVP and Chief IR OfficerDr.
Pfizer missed first quarter earnings Thursday amid a volatile macro environment. ... Pfizer reaffirmed its 2025 outlook of $61 to $64 billion in revenue and adjusted earnings per share of $2.80 to $3.